Literature DB >> 22674992

Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly.

Helen R Fryer1, John Frater, Anna Duda, Duncan Palmer, Rodney E Phillips, Angela R McLean.   

Abstract

Identifying human immunodeficiency virus (HIV) immune escape mutations has implications for understanding the impact of host immunity on pathogen evolution and guiding the choice of vaccine antigens. One means of identifying cytotoxic-T-lymphocyte (CTL) escape mutations is to search for statistical associations between mutations and host human leukocyte antigen (HLA) class I alleles at the population level. The impact of evolutionary rates on the strength of such associations is not well defined. Here, we address this topic using a mathematical model of within-host evolution and between-host transmission of CTL escape mutants that predicts the prevalence of escape mutants at the population level. We ask how the rates at which an escape mutation emerges in a host who bears the restricting HLA and reverts when transmitted to a host who does not bear the HLA affect the strength of an association. We consider the impact of these factors when using a standard statistical method to test for an association and when using an adaptation of that method that corrects for phylogenetic relationships. We show that with both methods, the average sample size required to identify an escape mutation is smaller if the mutation escapes and reverts quickly. Thus, escape mutations identified as HLA associated systematically favor those that escape and revert rapidly. We also present expressions that can be used to infer escape and reversion rates from cross-sectional escape prevalence data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674992      PMCID: PMC3421756          DOI: 10.1128/JVI.07020-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.

Authors:  Toshiyuki Miura; Chanson J Brumme; Mark A Brockman; Zabrina L Brumme; Florencia Pereyra; Brian L Block; Alicja Trocha; Mina John; Simon Mallal; P Richard Harrigan; Bruce D Walker
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

2.  Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.

Authors:  Thillagavathie Pillay; Hua-Tang Zhang; Jan W Drijfhout; Nicola Robinson; Helen Brown; Munira Khan; Jagadesa Moodley; Miriam Adhikari; Katja Pfafferott; Margaret E Feeney; Anne St John; Edward C Holmes; Hoosen M Coovadia; Paul Klenerman; Philip J R Goulder; Rodney E Phillips
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  A Hidden Markov Model approach to variation among sites in rate of evolution.

Authors:  J Felsenstein; G A Churchill
Journal:  Mol Biol Evol       Date:  1996-01       Impact factor: 16.240

4.  Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.

Authors:  Philippa C Matthews; Andrew Prendergast; Alasdair Leslie; Hayley Crawford; Rebecca Payne; Christine Rousseau; Morgane Rolland; Isobella Honeyborne; Jonathan Carlson; Carl Kadie; Christian Brander; Karen Bishop; Nonkululeko Mlotshwa; James I Mullins; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

5.  HIV evolution: CTL escape mutation and reversion after transmission.

Authors:  A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

6.  Adaptation of HIV-1 to human leukocyte antigen class I.

Authors:  Yuka Kawashima; Katja Pfafferott; John Frater; Philippa Matthews; Rebecca Payne; Marylyn Addo; Hiroyuki Gatanaga; Mamoru Fujiwara; Atsuko Hachiya; Hirokazu Koizumi; Nozomi Kuse; Shinichi Oka; Anna Duda; Andrew Prendergast; Hayley Crawford; Alasdair Leslie; Zabrina Brumme; Chanson Brumme; Todd Allen; Christian Brander; Richard Kaslow; James Tang; Eric Hunter; Susan Allen; Joseph Mulenga; Songee Branch; Tim Roach; Mina John; Simon Mallal; Anthony Ogwu; Roger Shapiro; Julia G Prado; Sarah Fidler; Jonathan Weber; Oliver G Pybus; Paul Klenerman; Thumbi Ndung'u; Rodney Phillips; David Heckerman; P Richard Harrigan; Bruce D Walker; Masafumi Takiguchi; Philip Goulder
Journal:  Nature       Date:  2009-02-25       Impact factor: 49.962

7.  Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.

Authors:  A J Frater; H Brown; A Oxenius; H F Günthard; B Hirschel; N Robinson; A J Leslie; R Payne; H Crawford; A Prendergast; C Brander; P Kiepiela; B D Walker; P J R Goulder; A McLean; R E Phillips
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

8.  Adaptation to different human populations by HIV-1 revealed by codon-based analyses.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost; Zehava Grossman; Michael B Gravenor; Douglas D Richman; Andrew J Leigh Brown
Journal:  PLoS Comput Biol       Date:  2006-06-23       Impact factor: 4.475

9.  Leveraging hierarchical population structure in discrete association studies.

Authors:  Jonathan Carlson; Carl Kadie; Simon Mallal; David Heckerman
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

10.  Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.

Authors:  Almut Scherer; John Frater; Annette Oxenius; Juliet Agudelo; David A Price; Huldrych F Günthard; Martin Barnardo; Luc Perrin; Bernard Hirschel; Rodney E Phillips; Angela R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

View more
  12 in total

1.  Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Authors:  Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Authors:  Justine E Sunshine; Brendan B Larsen; Brandon Maust; Ellie Casey; Wenje Deng; Lennie Chen; Dylan H Westfall; Moon Kim; Hong Zhao; Suvankar Ghorai; Erinn Lanxon-Cookson; Morgane Rolland; Ann C Collier; Janine Maenza; James I Mullins; Nicole Frahm
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

3.  Global Database-Driven Assessment of HIV-1 Adaptation to the Immune Repertoires of Human Populations.

Authors:  Aram Karakas; Zabrina L Brumme; Art F Y Poon
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

4.  SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.

Authors:  Chihiro Motozono; Mako Toyoda; Jiri Zahradnik; Akatsuki Saito; Hesham Nasser; Toong Seng Tan; Isaac Ngare; Izumi Kimura; Keiya Uriu; Yusuke Kosugi; Yuan Yue; Ryo Shimizu; Jumpei Ito; Shiho Torii; Akiko Yonekawa; Nobuyuki Shimono; Yoji Nagasaki; Rumi Minami; Takashi Toya; Noritaka Sekiya; Takasuke Fukuhara; Yoshiharu Matsuura; Gideon Schreiber; Terumasa Ikeda; So Nakagawa; Takamasa Ueno; Kei Sato
Journal:  Cell Host Microbe       Date:  2021-06-15       Impact factor: 21.023

5.  Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

Authors:  Laura A Cotton; Xiaomei T Kuang; Anh Q Le; Jonathan M Carlson; Benjamin Chan; Denis R Chopera; Chanson J Brumme; Tristan J Markle; Eric Martin; Aniqa Shahid; Gursev Anmole; Philip Mwimanzi; Pauline Nassab; Kali A Penney; Manal A Rahman; M-J Milloy; Martin T Schechter; Martin Markowitz; Mary Carrington; Bruce D Walker; Theresa Wagner; Susan Buchbinder; Jonathan Fuchs; Beryl Koblin; Kenneth H Mayer; P Richard Harrigan; Mark A Brockman; Art F Y Poon; Zabrina L Brumme
Journal:  PLoS Genet       Date:  2014-04-24       Impact factor: 5.917

6.  Structured observations reveal slow HIV-1 CTL escape.

Authors:  Hannah E Roberts; Jacob Hurst; Nicola Robinson; Helen Brown; Peter Flanagan; Laura Vass; Sarah Fidler; Jonathan Weber; Abdel Babiker; Rodney E Phillips; Angela R McLean; John Frater
Journal:  PLoS Genet       Date:  2015-02-02       Impact factor: 5.917

7.  Neutral Theory and Rapidly Evolving Viral Pathogens.

Authors:  Simon D W Frost; Brittany Rife Magalis; Sergei L Kosakovsky Pond
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

8.  Early immune adaptation in HIV-1 revealed by population-level approaches.

Authors:  Eric Martin; Jonathan M Carlson; Anh Q Le; Denis R Chopera; Rachel McGovern; Manal A Rahman; Carmond Ng; Heiko Jessen; Anthony D Kelleher; Martin Markowitz; Todd M Allen; M-J Milloy; Mary Carrington; Mark A Wainberg; Zabrina L Brumme
Journal:  Retrovirology       Date:  2014-08-29       Impact factor: 4.602

9.  Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.

Authors:  Diogo Gama Caetano; Fernanda Heloise Côrtes; Gonzalo Bello; Sylvia Lopes Maia Teixeira; Brenda Hoagland; Beatriz Grinsztejn; Valdilea Gonçalves Veloso; Monick Lindenmeyer Guimarães; Mariza Gonçalves Morgado
Journal:  Retrovirology       Date:  2018-09-10       Impact factor: 4.602

10.  APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.

Authors:  Faezeh Borzooee; Krista D Joris; Michael D Grant; Mani Larijani
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.